
Loading, please wait...

Loading, please wait...

The Multiethnic Cohort Study (MEC) represents a landmark effort in understanding multiethnic cancer risk factors. Specifically, this prospective cohort includes over 215,000 participants from diverse racial and ethnic backgrounds. By examining both genetic and non-genetic determinants, the study provides a robust framework for investigating health disparities. Doctors in India can draw vital parallels from this research, as the Indian subcontinent possesses immense genetic diversity. Furthermore, the MEC sub-cohort of 74,000 biospecimens allows for unprecedented genetic analysis on a global scale.
Researchers focused on identifying variations in risk across African Americans, Japanese Americans, Latinos, Native Hawaiians, and Whites. Notably, the study utilized a comprehensive Genetics Database containing genotype data for 73,139 participants. This data enabled multi-ancestry genome-wide association studies (GWAS) for common malignancies like breast, colorectal, and prostate cancer. Consequently, the researchers could evaluate how genetic similarity interacts with self-reported ethnicity and environmental factors. Because these cancers are prevalent in India, these findings emphasize the urgent need for population-specific risk assessment.
The results showed that genetic diversity is substantial across the cohort. However, the study also highlighted that Polygenic Risk Score (PRS) effects are not uniform across ethnicities. Specifically, PRS predictive power varied significantly depending on the ancestral background of the participant. Moreover, the researchers identified a clear link between neighborhood socioeconomic status (nSES) and cancer incidence. This intersection of biology and social environment suggests that risk prediction must be multi-faceted. Thus, clinicians should consider both genetic ancestry and lifestyle factors when assessing a patient's risk profile.
The MEC database supports the development of integrated risk prediction models. These models are crucial for reducing health disparities in diverse populations. For instance, replicating known genetic variants across multiple ancestries confirms the stability of certain biomarkers. Simultaneously, identifying population-specific risks helps in tailoring localized screening programs. Therefore, moving away from European-centric data is essential for achieving global health equity. In conclusion, the study advocates for a more inclusive approach to genetic research to improve outcomes for all ethnicities.
Diversity ensures that genetic risk markers are applicable to all populations. Most current data is European-centric, which can lead to inaccurate risk predictions for other ethnic groups like those in India.
The MEC study found significant associations between neighborhood socioeconomic status and cancer incidence. This suggests that environmental and social factors play as much of a role as genetics in determining absolute risk.
While polygenic risk scores are useful, their effectiveness varies between groups. The MEC study indicates that PRS models must be validated in specific ethnic cohorts to ensure clinical accuracy.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Bogumil D et al. The Multiethnic Cohort: A Resource for the study of Genetic and non-Genetic Cancer Risk Across Populations. Cancer Epidemiol Biomarkers Prev. 2026 May 01. doi: 10.1158/1055-9965.EPI-25-1458. PMID: 42065926.
Witte JS, et al. Leveraging Diversity in Cancer Epidemiology Cohorts and Novel Methods to Improve Polygenic Risk Scores. NIH RePORTER. 2020.
Carpten JD. Greater Diversity of Cancer Models May Help Combat Imprecision in Personalized Care. Targeted Oncology. 2020.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A study of 215,000+ participants reveals how genetic similarity and socioeconomic status influence cancer risk across diverse ethnic groups....
4 months ago

A 2026 meta-analysis evaluates PDE5 inhibitors in advanced ILD with severe gas exchange impairment. While overall mortality was not significantly reduced, a targeted subgroup with pulmonary hypertension showed a 49% risk reduction, underscoring the necessity of precise hemodynamic phenotyping.
Today

At the 79th Regional Committee session, the World Health Organization commended India's public health advancements. Key achievements include the operationalization of 160,000 Ayushman Arogya Mandirs, higher institutional delivery rates, strong ASHA networks, and persistent efforts to eliminate tuberculosis nationwide.
Today

The Supreme Court questioned FSSAI's phased warning approach, urging single-phase implementation for foods exceeding limits in any nutrient of concern. Backed by ICMR-NIN recommendations, the proposed red hexagonal warnings target added sugar, salt, and fat to combat India's escalating chronic disease epidemic.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

A comparative analysis shows that older age, elevated blood glucose, and abdominal adiposity are primary drivers of hypertension. Comprehensive evaluation of cardiometabolic risk profiles enables clinicians to detect overlapping metabolic dysfunctions early and optimize targeted prevention strategies.
Today